<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="612">
  <stage>Registered</stage>
  <submitdate>21/07/2005</submitdate>
  <approvaldate>21/07/2005</approvaldate>
  <nctid>NCT00123383</nctid>
  <trial_identification>
    <studytitle>Randomised Placebo-Controlled Trial of Modafinil for Cocaine Dependence</studytitle>
    <scientifictitle>Randomised Placebo-Controlled Trial of Modafinil for Cocaine Dependence</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>HREC05023</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Cocaine Dependence</healthcondition>
  </conditions>
  <interventions>
    <interventions>Treatment: drugs - Modafinil

Treatment: drugs: Modafinil


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Urinalysis negative for cocaine over 10 weeks</outcome>
      <timepoint>10 weeks</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Adverse events</outcome>
      <timepoint>10 weeks</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Compliance</outcome>
      <timepoint>10 weeks</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Retention</outcome>
      <timepoint>10 weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Self reported drug use</outcome>
      <timepoint>10 weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Health outcomes</outcome>
      <timepoint>10 weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Psychosocial outcomes</outcome>
      <timepoint>10 weeks</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  DSM-IV cocaine dependence diagnosis

          -  Cocaine positive urine sample at intake

          -  Regular current cocaine use (2-3 days per week)

          -  Aged 18 years or older</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Pregnant or nursing females

          -  Concurrent uncontrolled physical or mental illness</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2</phase>
    <anticipatedstartdate />
    <actualstartdate>1/07/2005</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>10</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Unknown status</recruitmentstatus>
    <anticipatedlastvisitdate>1/09/2007</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
    <hospital>Alcohol &amp; Drug Services, St Vincent's Hospital - Darlinghurst</hospital>
    <hospital>Kirketon Road Centre, Sydney Hospital - Darlinghurst</hospital>
    <postcode>2010 - Darlinghurst</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>The University of New South Wales</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Australian Government Department of Health and Ageing</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Kirketon Road Centre, Sydney Hospital</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>St Vincent's Hospital, Sydney</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The study aims to evaluate the safety and efficacy of modafinil (200 mg/day) over 10 weeks
      plus a tailored cognitive behavioural therapy program in the treatment of cocaine dependence.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00123383</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Richard P Mattick, PhD</name>
      <address>University of New South Wales</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>